← 產業報告目錄
Mental Health Screening Market Size, Share & Trends Analysis Report, By Indication (Physiological Disorders, Psychiatric Disorders Behavioral Disorders Cognitive Disorders), Screening Method (Self-reported Questionnaires & Surveys, Clinical Interviews, Observation-based Assessments, Biomarker Testing)), By Technology, By Age Group, By Setting, By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-31頁數 180報告編號 INSIGHTACE-7c9166a98b
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The worldwide Mental Health Screening Market stood at USD 1.04 Bn in 2023, and is set to reach USD 2.62 Bn by 2031, recording a CAGR of 12.5% from 2024 through 2031.
At its core, Mental Health Screening pertains to The Mental Health Screening Market is witnessing robust growth driven by rising awareness and initiatives for mental health, technological advancements, and mounting mental health disorders. Stakeholders across the healthcare landscape are mountingly turning to these solutions to meet contemporary demands.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Mental Health Screening Market Snapshot
Chapter 4. Global Mental Health Screening Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Indication Estimates & Trend Analysis
5.1. by Indication & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Indication:
5.2.1. Physiological Disorders
5.2.1.1. Depression
5.2.1.2. Anxiety
5.2.1.3. Post-Traumatic Stress Disorder (PTSD)
5.2.1.4. Bipolar Disorder
5.2.1.5. Eating Disorder
5.2.1.6. Substance Abuse
5.2.1.7. Other Physiological Disorders
5.2.2. Psychiatric Disorders
5.2.2.1. Schizophrenia
5.2.2.2. Psychotic Disorder
5.2.2.3. Dissociative Disorder
5.2.2.4. Obsessive Compulsive Disorder
5.2.2.5. Dissociative Disorder
5.2.2.6. Attention Deficit Hyperactivity Disorder (ADHD)
5.2.2.7. Other Psychiatric Disorders
5.2.3. Behavioral Disorders
5.2.3.1. Self-Harm
5.2.3.2. Aggression
5.2.3.3. Sleep Disorder
5.2.3.4. Social Withdrawal
5.2.3.5. Dissociative Disorder
5.2.3.6. Hyperactivity
5.2.3.7. Other Behavioral Disorders
5.2.4. Cognitive Disorders
5.2.4.1. Cognitive Impairment
5.2.4.2. Dementia
5.2.4.3. Alzheimer's Disease
5.2.4.4. Other Cognitive Disorders
Chapter 6. Market Segmentation 2: by Screening Method Estimates & Trend Analysis
6.1. by Screening Method & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Screening Method:
6.2.1. Self-reported Questionnaires & Surveys
6.2.1.1. Beck Depression Inventory (BDI)
6.2.1.2. Generalized Anxiety Disorder-7 (GAD-7)
6.2.1.3. Patient Health Questionnaire-12 (PHQ-12)
6.2.1.4. Hamilton Anxiety Rating Scale (HAM-A)
6.2.1.5. Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
6.2.1.6. Other Self-reported Questionnaires & Surveys
6.2.2. Clinical Interviews
6.2.2.1. Structured Clinical Interview for DSM (SCID)
6.2.2.2. Mini International Neuropsychiatric Interview (MINI)
6.2.2.3. Diagnostic Interview for Psychological Distress (DIPD)
6.2.2.4. Other Clinical Interviews
6.2.3. Observation-based Assessments
6.2.4. Biomarker Testing
Chapter 7. Market Segmentation 3: by Technology Estimates & Trend Analysis
7.1. by Technology & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
7.2.1. Self-screening mHealth Apps
7.2.2. Telehealth & Virtual Care Solutions
7.2.3. Continuous Monitoring Wearable Devices
7.2.4. AI-based Screening Tools
7.2.5. Remote Mental Health Platforms
Chapter 8. Market Segmentation 4: by Age Group Estimates & Trend Analysis
8.1. by Age Group & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Age Group:
8.2.1. Children & Adolescents (Age 0–18 Years)
8.2.2. Adults (Age 19–64)
8.2.3. Seniors (Age 65 and above)
Chapter 9. Market Segmentation 5: by Setting Estimates & Trend Analysis
9.1. by Setting & Market Share, 2019 & 2031
9.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Setting:
9.2.1. Clinical Settings
9.2.2. Educational Institutions
9.2.3. Workplace/Corporate Programs
9.2.4. Online Platforms
9.2.5. Other Settings
Chapter 10. Mental Health Screening Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.1.2. North America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Screening Method, 2019-2031
10.1.3. North America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.1.4. North America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Age Group, 2019-2031
10.1.5. North America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Setting, 2019-2031
10.1.6. North America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.2. Europe
10.2.1. Europe Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.2.2. Europe Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Screening Method ,2019-2031
10.2.3. Europe Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.2.4. Europe Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Age Group, 2019-2031
10.2.5. Europe Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Setting, 2019-2031
10.2.6. Europe Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.3. Asia Pacific
10.3.1. Asia Pacific Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.3.2. Asia Pacific Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Screening Method, 2019-2031
10.3.3. Asia-Pacific Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.3.4. Asia-Pacific Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Age Group, 2019-2031
10.3.5. Asia-Pacific Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Setting, 2019-2031
10.3.6. Asia Pacific Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.4. Latin America
10.4.1. Latin America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.4.2. Latin America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Screening Method, 2019-2031
10.4.3. Latin America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.4.4. Latin America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Age Group, 2019-2031
10.4.5. Latin America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Setting, 2019-2031
10.4.6. Latin America Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2019-2031
10.5.2. Middle East & Africa Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Screening Method, 2019-2031
10.5.3. Middle East & Africa Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2019-2031
10.5.4. Middle East & Africa Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Age Group, 2019-2031
10.5.5. Middle East & Africa Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by Setting, 2019-2031
10.5.6. Middle East & Africa Mental Health Screening Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Sondermind (Total Brain)
11.2.2. Riverside Community Care (Mindwise Innovations)
11.2.3. Proem Behavioral Health
11.2.4. Headspace Health
11.2.5. Quartet Health, Inc.
11.2.6. Clarigent Health
11.2.7. Ellipsis Health, Inc.
11.2.8. Adaptive Testing Technologies
11.2.9. Aiberry
11.2.10. Kintsugi Mindful Wellness, Inc.
11.2.11. Thymia Limited
11.2.12. Canary Speech, Inc.
11.2.13. Modern Life, Inc.
11.2.14. Sonde Health, Inc.
11.2.15. Futuresthrive
11.2.16. Koninklijke Philips N.V.
11.2.17. Alphabet Inc. (Fitbit)
11.2.18. Resmed Inc.
11.2.19. Apple Inc.
11.2.20. Cognitive Health Solutions
11.2.21. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們